Drug
pertuzumab, trastuzumab, and hyaluronidase-zzxf
Marketed as PHESGO.
Generic name
pertuzumab, trastuzumab, and hyaluronidase-zzxf
Brand names
PHESGO
First FDA approval
2020-06-29
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761170 | PHESGO | 2020-06-29 | GENENTECH INC |
Manufacturers
GENENTECH INC
Frequently asked questions
When was pertuzumab, trastuzumab, and hyaluronidase-zzxf FDA approved?
Earliest FDA approval on record: 2020-06-29.
What brand names are sold as pertuzumab, trastuzumab, and hyaluronidase-zzxf?
PHESGO.
Sources
Appeal a pertuzumab, trastuzumab, and hyaluronidase-zzxf denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com